Patient Outcomes
|
Management
|
Number (%) N = 104
|
Postoperative COVID-19 infection
|
None
|
0 (0.00%)
|
ITU admissions
|
None
|
0 (0.00%)
|
In-hospital deaths
|
None
|
0 (0.00%)
|
Postoperative complications
|
Management
|
Number (%) N = 104
|
Pulmonary embolism
|
Rivaroxaban for 3 months
|
2 (1.92%)
|
Transient ischemic attack
|
Self-resolved; readmitted for elective carotid endarterectomy
|
1 (0.96%)
|
Chest pain
|
Self-resolved; non-cardiac, non-pulmonary
|
1 (0.96%)
|
Fast atrial fibrillation (AF) new diagnosis
|
Beta blockers. Incidental finding of pheochromocytoma on CTPA requiring readmission to a tertiary centre for management
|
1 (0.96%)
|
Postoperative pyrexia
|
Negative RT-PCR swab and septic screen
|
3 (2.88%)
|
Deep joint infection (total knee replacement)
|
Readmitted for open washout of prosthetic joint
|
1 (0.96%)
|
Superficial wound infection post-knee arthroscopy
|
1 treated with oral antibiotics; 1 readmitted for 24 hour IV antibiotics
|
2 (1.92%)
|
Oozy wound
|
5 treated with pressure dressings; 1 required transfusion of blood products
|
6 (5.77%)
|
Symptomatic anaemia
|
Red blood cell transfusion
|
4 (3.85%)
|
Postoperative hypoglycaemia
|
GP referral for endocrine review
|
1 (0.96%)
|
Aborted surgery (irreparable chronic tear of pectoralis major tendon)
|
Referred to a tertiary centre
|
1 (0.96%)
|